‘Time for a Paradigm Shift’ in Depression Research
UT Southwestern Medical Center
A recent study conducted by the Department of Occupational and Environmental Health at Tongji Medical College, Huazhong University of Science and Technology, reveals a strong link between exposure to styrene and ethylbenzene, common air pollutants, and an increased risk of developing type 2 diabetes mellitus (T2DM).
Keck Hospital of USC has been named a top performer in the 2024 Bernard A. Birnbaum, MD, Quality Leadership award by Vizient, Inc., a leading health care performance improvement company.
Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.
Cerca de um terço da metade dos casos de câncer são evitáveis, de acordo com a Organização Mundial Da Saúde. O Dr. Jon Ebbert, diretor médico do Centro de Dependência de Nicotina da Mayo Clinic, diz que nunca é tarde demais para fazer mudanças no estilo de vida que possam diminuir o seu risco de desenvolver câncer.
Aproximadamente un tercio de la mitad de los casos de cáncer se pueden prevenir, según la Organización Mundial de la Salud. El Dr. Jon Ebbert, director médico del Centro de Adicción a la Nicotina de Mayo Clinic, dice que nunca es demasiado tarde para hacer cambios en el estilo de vida que puedan disminuir su riesgo de desarrollar cáncer.
روتشستر، ولاية مينيسوتا — يمكن الوقاية من حوالى ثلث إلى نصف حالات السرطان، وذلك وفقًا لتصريح منظمة الصحة العالمية. يقول جون إيبرت، دكتور في الطب، المدير الطبي لمركز علاج إدمان النيكوتين، أنه لم يفت الأوان أبدًا لإجراء تغييرات في نمط الحياة والتي من شأنها تقليل خطر الإصابة بمرض السرطان.
Three new studies pinpoint challenges and opportunities for closing health disparities for LGBTQ+ people, showing how the convergence of political and social environments, structural inequities, and implicit and explicit bias within the medical system erode LGBTQ+ well-being.
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib.
Amid southern california’s recent record-breaking heat wave and fast-moving wildfires, public health officials reported the third locally acquired case of dengue fever in the los angeles area. Although the events seem unrelated, they actually are connected—and for troubling reasons.
The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.
Renowned expert in building global health partnerships and HIV care to speak at the 2024 Concordia Annual Summit
We’re living much longer than our ancestors, but is that always a good thing? With many people living well into our late 70s or beyond, more of us are also spending a greater portion of our lives—sometimes a decade or more—saddled with physical and mental health conditions that can make it challenging to accomplish the tasks of daily life.
Northwestern University has been awarded $32.4 million over five years from the Hevolution Foundation to study proteostasis — the processes by which cells maintain protein health for good overall health and to prevent diseases of protein misfolding. A key goal is to improve the health people experience as they age, particularly in their final years.
Teri Boudreaux was one of more than 5,000 women who joined a clinical trial that was looking at the benefit of adding the targeted therapy drug ribociclib to conventional hormonal therapy for the adjuvant treatment of HR-positive, HER2-negative early-stage breast cancer. I
Hevolution Foundation and Dolby Family Ventures led Vandria’s Series A closing, bringing the capital to CHF 28.3. With the money, the 2021 EFPL spin-out aims to advance its first in class mitophagy inducer VNA-318 that targets several neurodegenerative indications into clinical development.
What if a drug could help you live a longer, healthier life? Scientists at the University of Connecticut are working on it. In a new study in Cell Metabolism, researchers described how to target specific cells to extend the lifespan and improve the health of mice late in life.
Wistar scientists have demonstrated the role of Parkin — a protein implicated in Parkinson's disease — in the body’s innate immune response to cancer.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies.
Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.